Laboratory & Research Equipment in Massachusetts
19 vendors serving Massachusetts
Find laboratory & research equipment vendors in Massachusetts. MedIndexer lists vendors headquartered in Massachusetts alongside nationwide vendors that serve Massachusetts. Compare profiles, review service areas, and contact vendors directly — no middleman, no fees for buyers.
Top laboratory & research equipment in Massachusetts
T2 Biosystems
T2 Biosystems, Inc. is a medical technology company based in Lexington, Massachusetts, founded in 2006. The company specializes in developing rapid diagnostic solutions for critical infections, aiming to meet significant healthcare needs. The core innovation of T2 Biosystems is its T2MR Technology, which utilizes magnetic resonance technology for direct pathogen detection from patient samples without the need for blood culture. This technology delivers results within 3-5 hours, greatly reducing the time required for diagnosis compared to traditional methods. The company offers a range of diagnostic panels, including the T2Dx Instrument Platform, T2Bacteria Panel, T2Candida Panel, T2SARS-CoV-2 Panel, and T2Resistance Panel, all designed to enhance the speed and accuracy of infectious disease detection. T2 Biosystems is committed to improving patient outcomes by enabling rapid diagnostic testing for bloodstream infections, allowing for quicker treatment initiation. The company is publicly traded on NASDAQ under the ticker symbol TTOO.
New England Biolabs
New England Biolabs (NEB) is a life sciences company based in Ipswich, Massachusetts, founded in 1974. The company specializes in the discovery, development, production, and supply of high-quality recombinant and native enzymes and reagents for molecular biology and genomic research. NEB was a pioneer in the commercial availability of restriction enzymes and has played a significant role in the advancement of recombinant DNA technology. NEB offers a wide range of products, including over 230 recombinant and 30 native restriction enzymes, as well as reagents for genome editing, synthetic biology, next-generation sequencing, PCR, and more. The company is committed to quality and innovation, supporting its own research initiatives and providing free research tools. With a global presence through subsidiaries and distributors, NEB serves researchers in academia and biotechnology, contributing to significant advancements in bioscience and genomic research.
Quintara Biosciences
Quintara Biosciences is a biotechnology company founded in 2005 and based in Cambridge, MA, with additional laboratory locations across the United States. The company specializes in life-science technologies that enhance drug discovery and development, operating as both a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) for the pharmaceutical industry. With around 77 employees and annual revenue of $17.7 million, Quintara is dedicated to providing high-quality services. The company offers a range of molecular biology services organized around four key platforms: DNA Reading, DNA Writing, DNA Production, and DNA Expression. Their capabilities include advanced sequencing technologies, oligonucleotide and gene synthesis, plasmid preparation, and antibody expression. Quintara serves a diverse clientele, including academia and industry, supporting various stages of drug development and research. Their mission focuses on delivering quality, speed, and value-driven services to empower researchers and accelerate scientific discovery.
Meadowhawk Biolabs, Inc.
Meadowhawk Biolabs, Inc. is a preclinical Contract Research Organization (CRO) founded in 2021. The company specializes in bioanalytical, pharmacokinetic, pharmacology, and in vivo services aimed at accelerating drug discovery and development for pharmaceutical and biotech clients. Headquartered in Marlborough, Massachusetts, Meadowhawk operates state-of-the-art, AAALAC-accredited laboratories in Boston and San Francisco, allowing for rapid study starts in as little as 24 hours. With a leadership team boasting over 30 years of combined experience in biotech, Meadowhawk emphasizes adaptability and precision in its services. The company offers non-GLP preclinical services, including LCMS bioanalysis, rodent in vivo studies, immunoanalytical services, and molecular assays. Its client-centric approach focuses on transparency and high-quality data delivery, supporting a wide range of drug modalities and fostering close collaboration with clients in major biotech hubs.
FORMULATRIX
FORMULATRIX is a life science automation company founded in 2002 and headquartered in Bedford, Massachusetts. The company designs and manufactures innovative software and robotic automation solutions tailored for the pharmaceutical and academic research industries. With a workforce of approximately 758-1,500 employees, FORMULATRIX generated $128.8 million in annual revenue as of 2024. The company specializes in laboratory automation solutions, including protein crystallization software and imaging systems, automated liquid handling technology, drop setters, and nucleic acid analysis solutions. These products are aimed at simplifying workflows such as sample preparation, high-throughput screening, and assay development, ultimately enabling scientific discoveries in proteomics and genomics. FORMULATRIX serves a prestigious customer base that includes major pharmaceutical companies and leading academic institutions. The company is committed to its core values of intelligence, hard work, divergent thinking, intellectual curiosity, sustainability, and honesty/trust.
Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc. is a synthetic biology company founded in 2008 by MIT scientists. The company specializes in genetic engineering to design and program microorganisms for various industrial applications, including agriculture, food, healthcare, energy, chemicals, cosmetics, and biosecurity. Ginkgo aims to make biology programmable, treating organisms as manufacturing platforms through DNA code insertion into microbes like bacteria and yeast. The company offers organism engineering services, which include designing, testing, and licensing custom microbes. Ginkgo's innovative approach allows for the creation of tailored strains for specific functions, supported by autonomous labs and biological foundries. Their work spans multiple sectors, providing solutions for crop optimization, ingredient production, therapeutics, and more. Ginkgo has established partnerships with around 20 companies, focusing on licensing engineered organisms rather than producing end-products directly.
Addgene
Addgene is a nonprofit scientific repository founded in 2004 that specializes in sharing genetic research materials, primarily plasmids, to support researchers globally. Established by Melina Fan, Kenneth Fan, and Benjie Chen, Addgene addresses the challenges of plasmid sharing by providing a centralized platform for distribution. The organization has grown significantly, reaching over 147,000 plasmids and shipping more than 2 million samples worldwide by its 20th anniversary in 2024. Addgene's main offering is a curated repository of high-quality plasmids, including over 15,000 related to CRISPR technology. The organization also provides services such as viral vectors, recombinant antibodies, and customizable reagents. With a focus on quality control and logistics, Addgene facilitates the deposition and distribution of plasmids, making it easier for researchers to access essential tools for genetic research. The repository has shipped plasmids to thousands of organizations, empowering collaboration and innovation in various fields of study.
Rapid Micro Biosystems
Rapid Micro Biosystems is a leader in automated detection of microbial contamination, primarily serving the pharmaceutical and biomanufacturing sectors. Headquartered in Lowell, Massachusetts, the company also has manufacturing operations in the U.S. and locations in Switzerland, Germany, and the Netherlands. Their mission focuses on enhancing microbial quality control processes through advanced automation and data integrity. The flagship product, the Growth Direct® System, is the first fully automated growth-based platform for traditional microbial testing. This system is designed for critical applications such as environmental monitoring, water testing, bioburden testing, and rapid sterility testing. It offers faster contamination detection, improved data integrity, and reduced operational risks, ultimately accelerating manufacturing timelines and increasing efficiency. Rapid Micro Biosystems caters to a diverse range of industries, including pharmaceuticals, biotechnology, medical devices, and personal care products. The company is particularly well-suited to support cell and gene therapies, which require rigorous microbial quality control. Recent funding of $81 million highlights the company's growth potential and strong market position.
BGI Genomics
BGI Genomics, established in 1999, is a prominent global provider of genomics and life science solutions. Originally part of the Beijing Genomics Institute, BGI has grown into one of the largest genomics organizations worldwide. The company has made significant contributions to major projects like the International Human Genome Project and the 1000 Genomes Project. With operations in over 60 countries, BGI emphasizes advancements in sequencing technologies, precision medicine, and agricultural applications. BGI offers a range of integrated solutions, including high-throughput DNA sequencing, bioinformatics, and diagnostic products. Their sequencing instruments, developed by MGI Tech, include ultra-high-throughput sequencers and clinical gene sequencers. BGI also provides diagnostic tests, such as the NIFTY test for prenatal screening and reagents for pathogen detection. Additionally, BGI engages in research services for drug development and agricultural engineering, and it supports education and talent training through BGI College. The company collaborates with various research institutions, medical facilities, and agricultural companies globally.
Harvard Apparatus
Harvard Apparatus is a prominent manufacturer of specialized scientific instruments for bioscience and physiological research, established in 1901 by Dr. William T. Porter. The company is known for its innovative contributions to life science tools, including the invention of the mechanical syringe pump and the first microprocessor-controlled syringe pumps. Its product lineup features advanced programmable syringe pumps, anesthesia and surgical systems, and a variety of monitoring and physiological tools. Headquartered in Holliston, Massachusetts, Harvard Apparatus operates globally, with locations in the U.S., U.K., Canada, France, and China. The company provides precision instruments for biomedical research, small animal surgery, and physiological studies, supporting applications in drug delivery, animal handling, and metabolic research. As part of Harvard Bioscience, it collaborates with affiliated brands to offer complementary tools in various fields, enhancing its capabilities in research and development.
Azenta Life Sciences
Azenta Life Sciences is a global provider of integrated sample exploration and management solutions. The company focuses on accelerating the discovery, development, and delivery of breakthroughs and therapies in the life sciences sector. Azenta emerged from the rebranding of Brooks Life Sciences and has a rich history of mergers and acquisitions, enhancing its capabilities in biobanking, sample management, and automated solutions. The company offers a wide range of products and services, including consumables, instruments, and software for sample management across various conditions. Key offerings include 2D sample storage tubes, robotic storage systems, laboratory information management systems (LIMS), and temperature-controlled storage solutions. Azenta emphasizes automation and informatics to improve data integrity and support research, clinical trials, and cell and gene therapy. Their solutions are designed to ensure sample quality, enhance workflows, and maximize the value of samples for life sciences organizations.
SeraCare
SeraCare Life Sciences is a prominent supplier of diagnostic quality controls, biological materials, and reagents for in vitro diagnostics developers, clinical laboratories, and life science researchers globally. Established in 1984 as Boston Biomedica Inc., the company is headquartered in Milford, Massachusetts, with an additional facility in Gaithersburg, Maryland. SeraCare has been a trusted partner in the diagnostic testing industry for over 30 years and is currently part of LGC, a KKR-backed company. The company offers a range of products, including ACCURUN® controls and reference materials, Seraseq® next-generation sequencing reference materials, customizable biological materials, and reagents for drug and vaccine development. SeraCare focuses on the evaluation and quality control of infectious disease tests and has a strong presence in the clinical next-generation sequencing market. Its customers include pharmaceutical companies, clinical laboratories, and in vitro diagnostics manufacturers, with sales primarily in the United States, Europe, and Asia. SeraCare operates ISO 13485-certified facilities and adheres to cGMP standards.
Emulate, Inc.
Emulate, Inc. is a biotechnology company focused on Organ-on-a-Chip technology. This innovative approach utilizes human cell-based microphysiological systems to replicate organ functions, aiding in drug development, toxicology, and human health research. Founded in 2013 as a spin-out from Harvard University's Wyss Institute, Emulate commercializes technology developed by Donald Ingber and his team, following significant research on lung functions. The company's Human Emulation System includes Organ-Chips, which are microfluidic devices designed to mimic human organ structures and functions. Emulate offers a range of products, including validated Bio-Kits for various organs and hardware solutions like the Zoë Culture Module and the AVA™ Emulation System. With over 30 organ models, Emulate supports research across multiple fields, including cancer, neuroscience, and personalized medicine. The company also provides fee-for-service partnerships for advanced studies and collaborates with notable organizations such as Roche, Takeda, and the U.S. FDA, emphasizing its commitment to innovation and reducing animal testing in research.
HighRes Biosolutions
HighRes Biosolutions is a global provider of laboratory automation solutions, established in 2004 and based in Beverly, Massachusetts. The company specializes in innovative robotic systems, modular hardware, orchestration software, and integrated workflows tailored for life science research. With a state-of-the-art facility spanning 50,000 square feet, HighRes employs around 144 people and generates approximately $36.1 million in revenue. The company designs and builds flexible and modular automation systems, including bench-top devices, semi-automated work cells, and complex enterprise-level solutions. Their offerings include advanced automation hardware, such as automated liquid handlers and the Nucleus Automation Infrastructure, as well as CellarioOS, a lab orchestration platform. HighRes supports various applications in drug discovery, high-throughput genotyping, and molecular diagnostics, emphasizing scalability and reliability. They serve a diverse clientele, including pharmaceutical companies, biotech firms, academic laboratories, and research institutes, with a commitment to enhancing scientific discovery.
Roche Middle East
Roche Middle East is the regional division of Roche, a leading global biotechnology company founded in 1896 in Basel, Switzerland. Operating in 16 countries across the Middle East, Roche Middle East serves as a hub for the company's pharmaceutical and diagnostic operations, ensuring alignment with global standards while enhancing local decision-making. Roche focuses on three main areas: Pharmaceuticals & Oncology, In-Vitro Diagnostics (IVD), and Digital Health Solutions. The company has a strong history in cancer research and treatment, providing medicines for various types of cancer and other health conditions. As a leader in in-vitro diagnostics, Roche offers reliable tests that support healthcare providers in delivering timely diagnostic information. Additionally, Roche develops digital health solutions to further improve health outcomes. Roche invests significantly in research and development, committing around 9 billion Swiss francs annually. The company is dedicated to preventing, diagnosing, and curing diseases while emphasizing environmental protection and social responsibility. In December 2022, Roche Diagnostics Middle East achieved ISO 27001 Information Security certification, highlighting its commitment to patient data protection.
Boston BioProducts
Boston BioProducts is a biological buffer and reagent manufacturer founded in 1995 and based in Ashland, Massachusetts. The company specializes in high-quality biological buffers, process liquids, and culture media for the life sciences industry. With a team of over 50 members, Boston BioProducts has evolved from a family-run business serving academic research facilities to a significant commercial supplier, generating approximately $6 million in annual revenue. The company offers a wide range of biological solutions, including buffers for protein purification, gel electrophoresis, and cell culture, as well as tailored process liquids and culture media for various applications. They also provide custom reagent manufacturing services, allowing for flexible formulations to meet specific laboratory needs. Boston BioProducts operates under a cGMP quality management system and holds ISO 13485 certification, ensuring high standards of quality assurance and comprehensive testing services. Their diverse clientele includes over 4,000 research laboratories, biotech companies, and academic researchers, all benefiting from their reliable and efficient products.
Advanced Instruments, LLC
Advanced Instruments, LLC is a global provider of scientific and analytical instruments, consumables, software, and services, primarily serving the biopharmaceutical, clinical, and food & beverage industries. Headquartered in Norwood, Massachusetts, the company has over 65 years of experience and operates in more than 90 countries. With a focus on service, quality, and reliability, Advanced Instruments aims to enhance efficiency, productivity, and regulatory compliance. The company offers a diverse range of products, including osmometers, clinical lab tools, microbiology solutions, and liquid handling systems. Their portfolio features the OsmoTECH® and OsmoPRO® micro-osmometers, GloCyte® for automated cell counts, and Anoxomat® for specialized environments. Recent strategic expansions include the acquisition of Artel and a merger with Nova Biomedical, enhancing their capabilities in bioprocessing, clinical diagnostics, and quality control. Advanced Instruments supports various applications, from drug manufacturing to food safety, helping organizations improve product quality and patient outcomes.
SmartLabs
SmartLabs, based in Boston and founded in 2015, provides flexible, pharma-grade research environments and managed laboratory infrastructure for life sciences, biotech, biopharma, and emerging technology companies. Their enterprise lab platform offers on-demand access to customizable, private labs, enabling clients to accelerate research and development without the burden of long-term leases or costly buildouts. The company specializes in managed research centers that include multifunctional labs, vivariums, and cGMP manufacturing capacity. Their lab-as-a-service model streamlines site selection, design, construction, and daily operations, significantly reducing time to readiness and capital costs. SmartLabs also offers shared resources for collaboration while ensuring the protection of intellectual property. With locations across the U.S. and a commitment to supporting over 120 diverse organizations, SmartLabs is dedicated to advancing life-saving therapies through adaptable and efficient research solutions.
Pillar Biosciences Incorporated
Pillar Biosciences Incorporated is a biotechnology company based in Natick, Massachusetts, founded in 2014. The company specializes in next-generation sequencing (NGS) diagnostics aimed at precision oncology and Decision Medicine™. It develops innovative, automatable technologies such as SLIMamp® and PiVAT® to facilitate rapid and cost-effective genomic tumor profiling, therapy selection, and recurrence monitoring. Pillar's mission is to make precision medicine accessible globally by providing streamlined, affordable clinical NGS workflows. Pillar offers a range of over 20 NGS testing kits in both in-vitro diagnostic (IVD) and research-use-only (RUO) formats, with additional products in development. Their solutions support the oncology ecosystem by delivering clinically actionable insights throughout patient care, from initial profiling to treatment guidance. The company collaborates with various healthcare providers, clinical labs, and biopharma companies, including a strategic partnership with Illumina for sequencing and bioinformatics.